We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$160B
AUM Growth
-$3.45B
Cap. Flow
-$2.94B
Cap. Flow %
-1.84%
Top 10 Hldgs %
28.21%
Holding
7,551
New
501
Increased
2,626
Reduced
3,452
Closed
568

Sector Composition

Rank Sector Weight
1 Technology 7.7%
2 Healthcare 5.71%
3 Financials 4.62%
4 Consumer Discretionary 4.5%
5 Communication Services 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRI icon
5451
CALL
Enviri
NVRI
$623M
$89K ﹤0.01%
4,700
+3,400
+262% +$72.1K
UBFO
5452
DELISTED
United Security Bancshares
UBFO
$89K ﹤0.01%
8,450
-511
-6% -$5.42K
NXGN
5453
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$89K ﹤0.01%
+5,700
New +$94.8K
HARP
5454
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$89K ﹤0.01%
653
+271
+71% +$38.1K
TCRR
5455
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$89K ﹤0.01%
5,885
+4,713
+402% +$73.4K
CBMG
5456
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$89K ﹤0.01%
5,967
-1,832
-23% -$24.7K
NBRV
5457
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$89K ﹤0.01%
+179
New +$101K
KVHI icon
5458
KVH Industries
KVHI
$181M
$88K ﹤0.01%
8,283
-2,454
-23% -$24.3K
LE icon
5459
Lands' End
LE
$370M
$88K ﹤0.01%
7,818
-4,167
-35% -$44K
PCYO icon
5460
Pure Cycle
PCYO
$253M
$88K ﹤0.01%
8,559
-2,479
-22% -$26.4K
SHG icon
5461
Shinhan Financial Group
SHG
$32.8B
$88K ﹤0.01%
2,503
+290
+13% +$10.3K
TDW icon
5462
CALL
Tidewater
TDW
$3.73B
$88K ﹤0.01%
5,800
TLPH icon
5463
Talphera
TLPH
$66.4M
$88K ﹤0.01%
2,025
-507
-20% -$24.9K
TWM icon
5464
CALL
ProShares UltraShort Russell2000
TWM
$44.3M
$88K ﹤0.01%
290
+115
+66% +$35K
CFFI icon
5465
C&F Financial
CFFI
$268M
$87K ﹤0.01%
1,661
-526
-24% -$26.9K
ESI icon
5466
PUT
Element Solutions
ESI
$8.95B
$87K ﹤0.01%
8,500
-11,000
-56% -$108K
MSCI icon
5467
CALL
MSCI
MSCI
$41.6B
$87K ﹤0.01%
+400
New +$92.7K
PLSE icon
5468
Pulse Biosciences
PLSE
$2.43B
$87K ﹤0.01%
5,590
-1,658
-23% -$21.5K
REPL icon
5469
Replimune Group
REPL
$941M
$87K ﹤0.01%
6,250
-1,257
-17% -$15.4K
UEC icon
5470
Uranium Energy
UEC
$4.75B
$87K ﹤0.01%
88,550
-27,351
-24% -$27.7K
GPX
5471
DELISTED
GP Strategies Corp.
GPX
$87K ﹤0.01%
6,789
-1,994
-23% -$28.1K
ALDR
5472
CALL
DELISTED
Alder Biopharmaceuticals
ALDR
$87K ﹤0.01%
+4,600
New +$52.6K
CDZI icon
5473
Cadiz
CDZI
$251M
$86K ﹤0.01%
6,966
-20,272
-74% -$242K
FDBC icon
5474
Fidelity D&D Bancorp
FDBC
$306M
$86K ﹤0.01%
1,382
-420
-23% -$26.2K
FLO icon
5475
CALL
Flowers Foods
FLO
$1.49B
$86K ﹤0.01%
3,700
-600
-14% -$13.9K

Similar funds

Barclays's Q3 2019 Portfolio in Review

As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
  • Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
  • Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
  • Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
  • Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
  • Barclays opened 501 new positions and closed 568 in Q3 2019.
  • Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.

Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.